Gallium-67 citrate in cerebral infarction

Area of Science:

• Nuclear medicine
• Radiology
• Neurology

Background:

• Cerebral infarction and tumors present diagnostic challenges.
• Radionuclide imaging is utilized for diagnosing brain lesions.

Purpose of the Study:

• To evaluate the diagnostic utility of gallium citrate (67Ga) in differentiating cerebral infarction from cerebral tumors.
• To compare the efficacy of 67Ga citrate with technetium-99m (99mTc) pertechnetate in cerebral lesion detection.

Main Methods:

• Cerebral scans were performed on 30 stroke patients.
• Patients underwent imaging with 99mTc pertechnetate followed by 67Ga citrate.
• Abnormalities in static and flow studies were recorded and compared between the two agents.

Main Results:

• 17 out of 26 patients (65%) with abnormal 99mTc scans showed similar abnormalities with 67Ga citrate.
• No significant difference in radioactivity concentration was observed between 67Ga and 99mTc in the lesions.
• Gallium citrate scans did not reveal abnormalities in patients with negative 99mTc static scans but positive flow studies.

Conclusions:

• Gallium citrate demonstrates nonspecificity in localizing cerebral lesions.
• 67Ga citrate is unable to differentiate cerebral infarction from cerebral tumors based solely on imaging localization.
• 99mTc pertechnetate appears to be a more effective agent for initial detection of cerebral abnormalities compared to 67Ga citrate.